Guidelines for Diagnosis and Treatment of Esophageal Cancer in TCM

Title: Guidelines for Diagnosis and Treatment of Esophageal Cancer in TCM
Edition: Updated
Classification: Traditional Chinese Medicine guideline
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: This guideline is suitable for use by related departments and clinicians such as the Department of Traditional Chinese Medicine, the Department of Integrated Traditional Chinese and Western Medicine, the Department of Internal Medicine, the Department of Oncology of the TCMedicine Hospital, and the grass-roots TCM physicians in general hospitals.
Evidence classification method: The evidence grading standards refer to the suggestions on the composition and grading of traditional medical evidence bodies proposed by Professor Liu Jianping in "Proposal for the Grading Standards of Traditional Chinese Medicine Clinical Evidence Based on Evidence Bodies" and "Proposals on the Composition and Grading Standards of Evidence in Real-World Research in Traditional Chinese Medicine". Level I Randomized controlled trials and their systematic reviews, systematic reviews of N-of-1 trials Level II Non-randomized clinical trials, cohort studies, N-of-1 trials Level III Case-control study, prospective case series Level IV Standardized expert consensus, retrospective case series, historical controlled studies Level V Non-standardized expert consensus, case report, experience summary Note: Standardized expert consensus refers to a document formulated by summarizing expert opinions through formal consensus methods (such as Delphi method, nominal group method, consensus meeting method, and modified Delphi method, etc.) to provide a basis for clinical decision-making; non- Standardized expert consensus refers to the expert experience documents summarized by the early application of informal consensus methods such as collective discussions, meetings, etc.
Development unit: 河南省中医院(河南中医药大学第二附属医院)
Registration time: 2022-05-15
Registration number: IPGRP-2022CN270
Purpose of the guideline: The purpose of this guideline revision is to further standardize the TCM diagnosis and treatment of Esophageal Cancer, recommend TCM diagnosis and treatment methods for Esophageal Cancer with evidence-based medical evidence, provide clinicians with strategies and methods for standardized treatment of Esophageal Cancer, and promote the clinical diagnosis and treatment of Esophageal Cancer. and the improvement of scientific research level. To guide clinical medical staff in the differentiation and medication of Esophageal Cancer, strengthen the management of patients with Esophageal Cancer, improve the awareness rate of patients and their families on the prevention and treatment of Esophageal Cancer, promote the treatment effect and the quality of life of patients, and reduce the mortality rate of Esophageal Cancer.